LitCovid-sample-Enju  

PMC:7199903 / 13028-13290 JSONTXT 14 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T66377 0-4 DT denotes This
T59113 5-13 VBZ denotes suggests
T7350 14-18 IN denotes that
T84608 19-22 DT denotes the
T79579 23-33 NN denotes SARS-CoV-2
T90817 34-35 NN denotes S
T46370 36-43 NN denotes protein
T49742 44-46 VBZ denotes is
T65139 47-51 RBR denotes less
T25953 52-59 RB denotes densely
T38725 60-72 VBN denotes glycosylated
T99018 73-76 CC denotes and
T61137 77-81 IN denotes that
T86967 82-85 DT denotes the
T63886 86-93 NNS denotes glycans
T21482 94-98 VBP denotes form
T93073 99-103 JJR denotes less
T83016 104-106 IN denotes of
T33280 107-108 DT denotes a
T85733 109-115 NN denotes shield
T30140 116-124 VBN denotes compared
T50036 125-129 IN denotes with
T75732 130-135 JJ denotes other
T97967 136-141 JJ denotes viral
T29563 142-155 NNS denotes glycoproteins
T29111 155-156 -COMMA- denotes ,
T12944 157-166 VBG denotes including
T78853 167-172 NN denotes HIV-1
T41077 173-176 NN denotes Env
T98405 177-180 CC denotes and
T41548 181-185 NN denotes LASV
T28392 186-189 NN denotes GPC
T20621 189-190 -COMMA- denotes ,
T35209 191-196 WDT denotes which
T31115 197-200 MD denotes may
T83078 201-203 VB denotes be
T44859 204-214 JJ denotes beneficial
T25244 215-218 IN denotes for
T31092 219-222 DT denotes the
T2299 223-234 NN denotes elicitation
T33174 235-237 IN denotes of
T63621 238-250 VBG denotes neutralizing
T62387 251-261 NNS denotes antibodies
R10503 T63886 T21482 arg1Of glycans,form
R10855 T46370 T38725 arg2Of protein,glycosylated
R17628 T93073 T83016 arg1Of less,of
R19015 T62387 T63621 arg1Of antibodies,neutralizing
R21364 T93073 T21482 arg2Of less,form
R21636 T28392 T41548 arg1Of GPC,LASV
R26595 T98405 T12944 arg2Of and,including
R28363 T29563 T75732 arg1Of glycoproteins,other
R2845 T50036 T30140 arg2Of with,compared
R31047 T61137 T99018 arg2Of that,and
R33571 T29563 T29111 arg1Of glycoproteins,","
R34491 T38725 T49742 arg2Of glycosylated,is
R38136 T83078 T31115 arg2Of be,may
R43307 T41077 T98405 arg1Of Env,and
R45773 T98405 T44859 arg1Of and,beneficial
R49051 T85733 T33280 arg1Of shield,a
R4957 T2299 T25244 arg2Of elicitation,for
R50116 T29563 T97967 arg1Of glycoproteins,viral
R50234 T25953 T65139 arg1Of densely,less
R51875 T41077 T78853 arg1Of Env,HIV-1
R55420 T98405 T31115 arg1Of and,may
R55823 T28392 T98405 arg2Of GPC,and
R56222 T38725 T99018 arg1Of glycosylated,and
R56244 T38725 T7350 arg1Of glycosylated,that
R58686 T38725 T25953 arg1Of glycosylated,densely
R60934 T44859 T25244 arg1Of beneficial,for
R63894 T44859 T83078 arg2Of beneficial,be
R72200 T63886 T86967 arg1Of glycans,the
R72516 T46370 T90817 arg1Of protein,S
R75177 T46370 T49742 arg1Of protein,is
R76475 T29563 T12944 arg1Of glycoproteins,including
R76881 T66377 T59113 arg1Of This,suggests
R78032 T98405 T20621 arg1Of and,","
R7869 T62387 T33174 arg2Of antibodies,of
R79137 T46370 T84608 arg1Of protein,the
R79430 T98405 T35209 arg1Of and,which
R85283 T2299 T31092 arg1Of elicitation,the
R8540 T2299 T33174 arg1Of elicitation,of
R86337 T46370 T79579 arg1Of protein,SARS-CoV-2
R86709 T99018 T59113 arg2Of and,suggests
R89424 T29563 T50036 arg2Of glycoproteins,with
R89854 T98405 T83078 arg1Of and,be
R94916 T21482 T61137 arg2Of form,that
R97132 T85733 T83016 arg2Of shield,of
R98481 T59113 T30140 arg1Of suggests,compared